Previous 10 | Next 10 |
Gainers: Wins Finance (NASDAQ: WINS ) +252% . More news on: Wins Finance Holdings Inc., DPW Holdings, Inc., Curis, Inc., Stocks on the move, , Read more ...
Immuron (NASDAQ: IMRN ) -37% . More news on: Immuron Limited, XpresSpa Group, Inc., Summit Wireless Technologies, Inc., Stocks on the move, , Read more ...
Are These The Best Biotech Stocks To Watch In June 2020? Investors seeking to outperform the market might want to take a look at biotech stocks . It doesn’t matter if you like momentum, speculation, or just pure fundamentals. There are plenty of biotech stocks to watch in 2020 . With ...
IZEA Worldwide (NASDAQ: IZEA ) +79% . More news on: IZEA Worldwide, Inc., Second Sight Medical Products, Inc., Immuron Limited, Stocks on the move, , Read more ...
Thinly traded nano cap Immuron Limited (NASDAQ: IMRN ) jumps 27% premarket on increased volume in reaction to its announcement that collaborator Naval Medical Research Center (NMRC) has requested a pre-IND meeting with the FDA regarding an IND for a new oral therapeutic to trea...
Key Points NMRC requests Pre-IND meeting with FDA on the development of a new oral therapeutic targeting Campylobacter and ETEC Two human phase II clinical trials to be conducted in 2021 One trial will focus on the ability of the hyperimmune product to protect volunteers agai...
MELBOURNE, Australia, April 28, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, today announced that the cash payments of ...
Gainers: Cyclacel Pharmaceuticals (NASDAQ: CYCC ) +91% . More news on: Cyclacel Pharmaceuticals, Inc., Benitec Biopharma Limited, VBI Vaccines Inc., Stocks on the move, , Read more ...
Ultra-thinly traded nano cap Immuron Limited ( IMRN +36.2% ) is up on a healthy 54x surge in volume, albeit on turnover of only 557K shares, on the heels of its fiscal Q3 results . Highlights: More news on: Immuron Limited, Healthcare stocks news, Stocks on the move, Consumer stocks new...
Key Highlights: North American sales up by 95% YoY in Q3 FY20 Immuron achieved 60% YoY growth in worldwide product sales in Q3 FY20. YTD March 31, FY20 worldwide sales reached AU $2.67M, increasing 57% YoY. In Australia, Q3 FY20 gross sales grew by 35% YoY to $475K. In the USA, ...
News, Short Squeeze, Breakout and More Instantly...
Sales Highlights: MELBOURNE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce record sales (unaudited) of Travelan ® , an over-the-counter immune ...
MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has filed a pre-IND (investigational new drug) application with the United States Food and Drug A...
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as Non-Executive Director effective today. Roger was appointed a...